Back to results
US 2023/0174470 A1Published application
Compound as a ubr box domain ligand
AssigneeAutotac Inc.
InventorsYong Tae KWON, Hyun Tae KIM, Jeong Eun NA, Yu Jin SEO, Chang Hoon JI, Ha Rim CHOI, Ji Eun LEE, Ah Jung HEO
Life of this patent
Estimating the term…
Abstract
The present specification relates to a compound as a UBR box domain ligand. The present specification provides a small molecule compound that binds to the UBR box domain. Further, the present specification provides a composition for inhibiting UBR box domain substrate binding, including a ligand compound that binds to a UBR box domain, a pharmaceutical composition for treating UBR-related disease, and a use thereof.
Claims20
A compound having the structure of formula 1:
- or a salt thereof,
- wherein the X1 is an optionally substituted with one or more R2 or unsubstituted phenyl, cycloalkyl or heterocyclyl;
- each R2 is independently selected from alkyl, alkoxy, amino, aminoalkyl, —NO2, ═O, —NHC2H4OH, —C(═NH)NH2, —C(═O)NH2, —C(═O)NHCH3, —C(═O)OH, phenyl or heterocycloalkyl;
- X4 is an optionally substituted with one or more R3 or unsubstituted phenyl, cycloalkyl or heterocyclyl;
- each R3 is independently selected from alkyl, alkoxy, amino, halo, hydroxyl, alkylamino, dialkylamino, —NO2, —CONR′R″, —CO2R′, —NHCOR′, phenyl or heterocycloalkyl;
- each R′ and R″ is independently —H or alkyl;
- X2 is SO2 or CRaRb;
- Ra and Rb are each independently H or CHs;
- X3 is NH or CH2;
- B1 is CH2 or NH;
- A1 is CH2 or NH.
8 more elements
Dependencies are inferred from the claim text.